Author:
Hughes Daniel Johnathan,Cook Gary JR,McLean Emma,Smith Daniel,King Juliet,Diamantopoulos Athanasios,Jones Aled,Neat Michael,Santis George,Spicer James,Karapanagiotou Eleni,Georgiou Alexandros
Reference15 articles.
1. EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII);Midha;Am. J. Cancer Res.,2015
2. Osimertinib in untreated EGFR-mutated advanced non–small-cell lung cancer;Soria;N. Engl. J. Med.,2018
3. Suda K., Murakami I., Sakai K., Mizuuchi H., Shimizu S., Sato K., et al. Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer. 2015;5:14447.
4. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors;Sequist;Sci. Transl. Med.,2011
5. EGFR-mutant adenocarcinomas that transform to small-cell lung cancer and other neuroendocrine carcinomas: clinical outcomes;Marcoux;J. Clin. Oncol.,2019
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献